North America Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Feb 2022
  • North America
  • 350 Pages
  • No of Tables: 165
  • No of Figures: 49

North America Interventional Cardiology Peripheral Vascular Devices Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD 9,596.92 Million
Diagram Market Size (Forecast Year)
USD 3.27 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Medtronic
  • BD
  • Cordis
  • Abbott
  • Boston Scientific Corporation

North America Interventional Cardiology and Peripheral Vascular Devices Market, By Product (Angioplasty Balloons, Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Accessories and Hemodynamic Flow Alteration Devices), Type (Conventional and Standard), Procedure (Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy and Peripheral Atherectomy), Indication (Peripheral Arterial Disease And Coronary Intervention), Age Group (Geriatric, Adults and Pediatric) End User (Hospitals, Ambulatory Surgery Centers, Nursing Facilities, Clinics and Others), Distribution Channel (Direct Tender, Third Party Distributors and Others), Country (U.S., Canada & Mexico) Industry Trends and Forecast to 2029 

North America Interventional Cardiology and Peripheral Vascular Devices Market

Market Analysis and Insights : North America Interventional Cardiology and Peripheral Vascular Devices Market

 North America interventional cardiology and peripheral vascular devices market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.7% in the forecast period of 2022 to 2029 and is expected to reach USD 16,651.03 million by 2029 from USD 9,596.92 million in 2021. The increased prevalence of coronary artery diseases, ischemic heart disease, and vascular disease, the surge in awareness about the timely treatment and use of the devices are likely to be the major drivers which propel the demand of the market in the forecast period.

The term interventional cardiology is an area of medicine within the subspecialty of cardiology and peripheral vascular devices that uses enhanced, conventional and advanced, and other diagnostic techniques to evaluate blood flow and pressure in the coronary arteries and chambers of the heart, as well as technical procedures and medications to treat abnormalities that impair the function of the cardiovascular system. The interventional cardiology and peripheral vascular devices are used since the devices make changes in a sedentary lifestyle. It reduces the complications of chronic cardiac diseases, such as coronary artery disease, ischemic heart disease, and vascular diseases.

Coronary heart disease is the leading cause of death among women. The knowledge about heart and vascular disease can impart healthy lifestyle. Adequate awareness about symptoms and their risk factors may help reduce the population's exposure to modifiable risk factors and contribute to prevention and control strategies. The awareness about the symptoms of cardiovascular and vascular diseases would result in timely treatment.

The drivers responsible for the growth of the North America interventional cardiology and peripheral vascular devices market are the increased prevalence of coronary artery diseases, ischemic heart disease and vascular disease, the surge in awareness about the timely treatment and use of the devices, technological advancements in the cardiology and peripheral vascular devices, increased interest towards non-invasive surgery and favorable reimbursement policies. However, the factors that are expected to restrain the market are the rise in the cost of the devices, the risks observed while using the devices, the rise in product recall, and the availability of alternate treatments. On the other hand, strategic initiatives by market players, rise in healthcare expenditure and increase in research and development activities, and growth in the geriatric population may act as an opportunity for the growth of the North America interventional cardiology and peripheral vascular devices market. The need for skilled expertise, lack of hospital infrastructure, and regulatory approval may create challenges for the North America interventional cardiology and peripheral vascular devices market.

The North America interventional cardiology and peripheral vascular devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Interventional Cardiology and Peripheral Vascular Devices Market

North America Interventional Cardiology and Peripheral Vascular Devices Market Scope and Market Size

The North America interventional cardiology and peripheral vascular devices market is categorized into seven segments: product, type, procedure, indication, age group, end user, and distribution channel.

  • Based on product, the North America interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, accessories, and hemodynamic flow alteration devices. In 2022, the angioplasty balloons segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market due to an increase in cases of peripheral arterial diseases, increased risk of a sedentary lifestyle, technological advancements in the angioplasty balloons, and the presence of reimbursement policies in healthcare in the U.S. for treatment of cardiac diseases.
  • Based on type, the North America interventional cardiology and peripheral vascular devices market is segmented into conventional and standard. In 2022, the conventional segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market due to the rising prevalence of cardiovascular diseases such as coronary artery diseases, carotid artery diseases, and availability and preference of the conventional interventional cardiology and peripheral vascular devices, by doctors and cardiologists, working in the U.S. and Canada hospitals.
  • Based on procedure, the North America interventional cardiology and peripheral vascular devices market is segmented into iliac intervention, femoropopliteal interventions, tibial (below-the-knee) interventions, peripheral angioplasty, arterial thrombectomy, and peripheral atherectomy. In 2022, the peripheral angioplasty segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market due to technological advancement over the past decade with advanced peripheral angioplasty devices.
  • Based on indication, the North America interventional cardiology and peripheral vascular devices market is segmented into peripheral arterial disease and coronary intervention. In 2022, the peripheral arterial disease segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market due to an increase in peripheral arterial diseases, a rise in the elderly population, and a rise in product approvals.
  • Based on age group, the North America interventional cardiology and peripheral vascular devices market is segmented into geriatric, adults and paediatric. In 2022, the geriatric segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market. They are more vulnerable with weak immunity for various vascular disorders and availability of reimbursement policies, such as Medicare for treatment of elderly population at minimum cost, in the U.S.
  • Based on end user, the North America interventional cardiology and peripheral vascular devices market is segmented into hospitals, ambulatory surgery centers, nursing facilities, clinics and others. In 2022, the hospitals segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market due to rise in chronic cardiac disorders, such as coronary artery disease and vascular diseases, rise in surgeries, availability of advanced hospital facilities, and rise in awareness about the treatment of chronic cardiac morbidities in hospitals are predicted to dominate the market.
  • Based on distribution channel, the North America interventional cardiology and peripheral vascular devices market is segmented into direct tenders, third party distributors, and others. In 2022, the third party distributors segment is expected to dominate the North America interventional cardiology and peripheral vascular devices market due to rising customer preference, low procurement prices, and reduced cost savings.

North America Interventional Cardiology and Peripheral Vascular Devices Market Country Level Analysis

The North America interventional cardiology and peripheral vascular devices market is analysed and market size information is provided by product, type, procedure, indication, age group, end user and distribution channel.

The countries covered in the North America interventional cardiology and peripheral vascular devices market report are the U.S., Canada, and Mexico.

  • In 2022, U.S. is expected to dominate due to the presence of the largest consumer market with high GDP. Moreover, the U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products, rise in patient populace, presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The growth potential for interventional cardiology and peripheral vascular devices in emerging economies and the strategic initiatives by market players are creating new opportunities in the North America interventional cardiology and peripheral vascular devices market

North America interventional cardiology and peripheral vascular devices market also provides you with detailed market analysis for every country growth in particular industry with the interventional cardiology and peripheral vascular devices sales, impact of advancement in the interventional cardiology and peripheral vascular devices and changes in regulatory scenarios with their support for the interventional cardiology and peripheral vascular devices market. The data is available for historic period 2019 to 2021.

Competitive Landscape and North America Interventional Cardiology and Peripheral Vascular Devices Market Share Analysis

North America interventional cardiology and peripheral vascular devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the interventional cardiology and peripheral vascular devices market.

Some major companies providing the interventional cardiology and peripheral vascular devices are Medtronic, BD., Cordis., Abbott., Boston Scientific Corporation, Cook, Cardiovascular Systems, Inc., AngioDynamics., Edwards Lifesciences Corporation., Biosensors International Group, Ltd., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co.,Ltd and Koninklijke Philips N.V. among others.

DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for North America interventional cardiology and peripheral vascular devices is bridging the gap for chronic wounds treatment. 

For instance,

  • In January 2022, OrbusNeich Medical Co. Ltd. announced that the company launched their new product “Scoreflex NC” and got Premarket Approval (PMA) from U.S. Food and Drug Administration (FDA). This product is a catheter that is intended to be used as dilation catheter in stenotic portion of coronary artery stenosis, thereby expanding their products for the market.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the interventional cardiology and peripheral vascular devices market which also provides the benefit for organisation to improve their offering for North America interventional cardiology and peripheral vascular devices market.

 

 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 THE RISE IN PREVALENCE OF CHRONIC DISEASES, SUCH AS CORONARY ARTERY DISEASE, ISCHEMIC HEART DISEASE AND VASCULAR DISEASES

6.1.2 AWARENESS AMONG THE POPULATION ABOUT THE TREATMENT AND USE OF THE DEVICES

6.1.3 TECHNOLOGICAL ADVANCEMENTS IN THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6.1.4 FAVORABLE REIMBURSEMENT POLICIES

6.1.5 INCREASED INTEREST FOR MINIMALLY INVASIVE PROCEDURES

6.2 RESTRAINTS

6.2.1 RISE IN COST OF THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6.2.2 RISKS OBSERVED WHILE USING INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6.2.3 RISE IN PRODUCT RECALL

6.2.4 AVAILABILITY OF ALTERNATE TREATMENTS

6.3 OPPORTUNITIES

6.3.1 GROWING GERIATRIC POPULATION

6.3.2 RISING HEALTHCARE EXPENDITURE

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES

6.4 CHALLENGES

6.4.1 STRINGENT RULES & REGULATIONS

6.4.2 LACK OF HOSPITAL INFRASTRUCTURE

7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET

7.1 PRICE IMPACT

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISIONS FOR MANUFACTURERS/ SERVICE PROVIDERS

7.5 CONCLUSION

8 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 ANGIOPLASTY BALLOONS

8.2.1 OLD/NORMAL BALLOONS

8.2.2 DRUG ELUTING BALLOONS

8.2.3 CUTTING AND SCORING BALLOONS

8.3 STENT

8.3.1 ANGIOPLASTY STENTS

8.3.2 CORONARY STENTS

8.3.2.1 BARE-METAL STENTS

8.3.2.2 DRUG-ELUTING STENTS (DES)

8.3.2.3 BIO ABSORBABLE STENTS

8.3.3 PERIPHERAL STENTS

8.3.4 OTHERS

8.4 CATHETERS

8.4.1 ANGIOGRAPHY CATHETERS

8.4.2 GUIDING CATHETERS

8.4.3 OTHERS

8.5 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

8.5.1 ABDOMINAL AORTIC ANEURYSM

8.5.2 THORACIC AORTIC ANEURYSM

8.6 INFERIOR VENA CAVA (IVC) FILTERS

8.6.1 RETRIEVABLE FILTERS

8.6.2 PERMANENT FILTERS

8.7 PLAQUE MODIFICATION DEVICES

8.7.1 THROMBECTOMY DEVICES

8.7.2 ATHERECTOMY DEVICES

8.8 HEMODYNAMIC FLOW ALTERATION DEVICES

8.8.1 EMBOLIC PROTECTION DEVICES

8.8.2 CHRONIC TOTAL OCCLUSION DEVICES

8.9 OTHERS AND ACCESSORIES

8.9.1 GUIDEWIRES

8.9.2 INTRODUCER SHEATHS

8.9.3 BALLOON INFLATION DEVICES

8.9.4 VASCULAR CLOSURE DEVICES

8.9.5 OTHERS

9 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

9.1 OVERVIEW

9.2 CONVENTIONAL

9.2.1 STENTS

9.2.2 CATHETERS

9.2.3 GUIDEWIRES

9.2.4 VASCULAR CLOSURE DEVICES (VCD)

9.2.5 OTHERS

9.3 ADVANCED

9.3.1 BALLOON CATHETERS

9.3.2 STENT GRAFTS

10 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE

10.1 OVERVIEW

10.2 PERIPHERAL ANGIOPLASTY

10.2.1 ANGIOPLASTY BALLOONS

10.2.2 STENT

10.2.3 CATHETERS

10.2.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.2.5 INFERIOR VENA CAVA (IVC) FILTERS

10.2.6 PLAQUE MODIFICATION DEVICES

10.2.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.2.8 OTHERS AND ACCESSORIES

10.3 ILIAC INTERVENTION

10.3.1 ANGIOPLASTY BALLOONS

10.3.2 STENT

10.3.3 CATHETERS

10.3.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.3.5 INFERIOR VENA CAVA (IVC) FILTERS

10.3.6 PLAQUE MODIFICATION DEVICES

10.3.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.3.8 OTHERS AND ACCESSORIES

10.4 TIBIAL (BELOW-THE-KNEE) INTERVENTIONS

10.4.1 ANGIOPLASTY BALLOONS

10.4.2 STENT

10.4.3 CATHETERS

10.4.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.4.5 INFERIOR VENA CAVA (IVC) FILTERS

10.4.6 PLAQUE MODIFICATION DEVICES

10.4.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.4.8 OTHERS AND ACCESSORIES

10.5 ARTERIAL THROMBECTOMY

10.5.1 ANGIOPLASTY BALLOONS

10.5.2 STENT

10.5.3 CATHETERS

10.5.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.5.5 INFERIOR VENA CAVA (IVC) FILTERS

10.5.6 PLAQUE MODIFICATION DEVICES

10.5.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.5.8 OTHERS AND ACCESSORIES

10.6 PERIPHERAL ATHERECTOMY

10.6.1 ANGIOPLASTY BALLOONS

10.6.2 STENT

10.6.3 CATHETERS

10.6.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.6.5 INFERIOR VENA CAVA (IVC) FILTERS

10.6.6 PLAQUE MODIFICATION DEVICES

10.6.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.6.8 OTHERS AND ACCESSORIES

10.7 FEMOROPOPLITEAL INTERVENTIONS

10.7.1 ANGIOPLASTY BALLOONS

10.7.2 STENT

10.7.3 CATHETERS

10.7.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.7.5 INFERIOR VENA CAVA (IVC) FILTERS

10.7.6 PLAQUE MODIFICATION DEVICES

10.7.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.7.8 OTHERS AND ACCESSORIES

11 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION

11.1 OVERVIEW

11.2 PERIPHERAL ARTERIAL DISEASE

11.2.1 ATHEROSCLEROSIS

11.2.2 ABDOMINAL AORTIC ANEURYSM

11.2.3 LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE

11.2.4 SUPRA-INGUINAL ARTERIAL DISEASE

11.2.5 INFRA-INGUINAL ARTERIAL DISEASE

11.2.6 INFRA-POPLITEAL DISEASE

11.2.7 UPPER EXTREMITY OCCLUSIVE DISEASE

11.2.8 CAROTID ARTERY DISEASE

11.2.9 OTHERS

11.3 CORONARY INTERVENTION

11.3.1 ISCHEMIC HEART DISEASE

11.3.2 THORACIC AORTIC ANEURYSM

11.3.3 VALVE DISEASE

11.3.4 PERCUTANEOUS VALVE REPAIR OR REPLACEMENT

11.3.5 CONGENITAL HEART ABNORMALITIES

11.3.6 OTHERS

12 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP

12.1 OVERVIEW

12.2 GERIATRIC

12.3 ADULTS

12.4 PEDIATRIC

13 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.2.1 PRIVATE

13.2.2 PUBLIC

13.3 AMBULATORY SURGICAL CENTERS

13.4 NURSING FACILITIES

13.5 CLINICS

13.6 OTHERS

14 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 THIRD PARTY DISTRIBUTORS

14.3 DIRECT TENDER

14.4 OTHERS

15 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY

15.1 NORTH AMERICA

15.1.1 U.S.

15.1.2 CANADA

15.1.3 MEXICO

16 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 BOSTON SCIENTIFIC CORPORATION

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENT

18.1.6 ACQUSITION

18.2 CORDIS.

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENTS

18.2.6 PRODUCT LAUNCHES

18.3 ABBOTT

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.3.6 PRODUCT LAUNCHES

18.4 BD (2021)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENT

18.5 TERUMO CORPORATION

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.5.6 PARTNERSHIP

18.5.7 PRODUCT LAUNCH

18.6 ANGIODYNAMICS.(2021)

18.6.1 COMPANY SNAPSHOT

18.6.2 REVENUE ANALYSIS

18.6.3 PRODUCT PORTFOLIO

18.6.4 RECENT DEVELOPMENTS

18.7 B. BRAUN MELSUNGEN AG (2021)

18.7.1 COMPANY SNAPSHOT

18.7.2 REVENUE ANALYSIS

18.7.3 PRODUCT PORTFOLIO

18.7.4 RECENT DEVELOPMENTS

18.8 BIOSENSORS INTERNATIONAL GROUP, LTD.

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

18.9 CARDIOVASCULAR SYSTEMS, INC. (2021)

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENTS

18.1 COOK

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENTS

18.10.4 EXPANSION

18.10.5 PRODUCT LAUNCHES

18.11 EDWARDS LIFESCIENCES CORPORATION

18.11.1 COMPANY SNAPSHOT

18.11.2 REVENUE ANALYSIS

18.11.3 PRODUCT PORTFOLIO

18.11.4 RECENT DEVELOPMENTS

18.12 KONINKLIJKE PHILIPS N.V.

18.12.1 COMPANY SNAPSHOT

18.12.2 REVENUE ANALYSIS

18.12.3 PRODUCT PORTFOLIO

18.12.4 RECENT DEVELOPMENTS

18.12.5 PRODUCT UPDATES

18.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (2021)

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENT

18.14 MEDTRONIC

18.14.1 COMPANY SNAPSHOT

18.14.2 REVENUE ANALYSIS

18.14.3 PRODUCT PORTFOLIO

18.14.4 RECENT DEVELOPMENTS

18.14.5 COLLABORATION

18.14.6 PRODUCT LAUNCH

18.15 MERIT MEDICAL SYSTEM

18.15.1 COMPANY SNAPSHOT

18.15.2 REVENUE ANALYSIS

18.15.3 PRODUCT PORTFOLIO

18.15.4 RECENT DEVELOPMENTS

18.16 MICROPORT SCIENTIFIC CORPORATION.

18.16.1 COMPANY SNAPSHOT

18.16.2 REVENUE ANALYSIS

18.16.3 PRODUCT PORTFOLIO

18.16.4 RECENT DEVELOPMENTS

18.16.4.1 PRODUCT APPROVALS

18.17 ORBUSNEICH MEDICAL COMPANY LIMITED

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENT

18.17.4 PRODUCT LAUNCH

18.18 SMT

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 TELEFLEX INCORPORATED.

18.19.1 COMPANY SNAPSHOT

18.19.2 REVENUE ANALYSIS

18.19.3 PRODUCT PORTFOLIO

18.19.4 RECENT DEVELOPMENTS

18.19.5 ACQUISITIONS

18.2 W. L. GORE & ASSOCIATES, INC.

18.20.1 COMPANY SNAPSHOT

18.20.2 PRODUCT PORTFOLIO

18.20.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

List of Table

TABLE 1 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 2 NORTH AMERICA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA STENT IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA GERIATRIC IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA ADULTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA PEDIATRIC IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA NURSING FACILITIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA CLINICS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 NORTH AMERICA OTHERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 53 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 54 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 NORTH AMERICA DIRECT TENDER IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 56 NORTH AMERICA OTHERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 57 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 58 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 59 NORTH AMERICA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 60 NORTH AMERICA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 61 NORTH AMERICA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 62 NORTH AMERICA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 63 NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 64 NORTH AMERICA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 NORTH AMERICA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 NORTH AMERICA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 67 NORTH AMERICA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 68 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 NORTH AMERICA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 NORTH AMERICA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 71 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 72 NORTH AMERICA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 73 NORTH AMERICA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 74 NORTH AMERICA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 75 NORTH AMERICA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 76 NORTH AMERICA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 77 NORTH AMERICA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 78 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 79 NORTH AMERICA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 80 NORTH AMERICA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 81 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 82 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 83 NORTH AMERICA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 84 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 85 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 86 U.S. ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 87 U.S. STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 88 U.S. CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 89 U.S. CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 90 U.S. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 91 U.S. INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 92 U.S. PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 93 U.S. HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 94 U.S. OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 95 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 U.S. CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 U.S. ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 99 U.S. ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 100 U.S. FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 101 U.S. TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 102 U.S. PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 103 U.S. ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 104 U.S. PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 105 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 106 U.S. PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 107 U.S. CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 108 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 109 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 110 U.S. HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 111 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 112 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 113 CANADA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 114 CANADA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 115 CANADA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 116 CANADA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 117 CANADA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 118 CANADA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 119 CANADA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 120 CANADA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 121 CANADA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 122 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 CANADA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 CANADA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 126 CANADA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 127 CANADA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 128 CANADA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 129 CANADA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 130 CANADA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 131 CANADA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 132 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 133 CANADA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 134 CANADA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 135 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 136 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 137 CANADA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 138 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 139 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 140 MEXICO ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 141 MEXICO STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 142 MEXICO CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 143 MEXICO CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 144 MEXICO ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 145 MEXICO INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 146 MEXICO PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 147 MEXICO HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 148 MEXICO OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 149 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 150 MEXICO CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 MEXICO ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 153 MEXICO ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 154 MEXICO FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 155 MEXICO TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 156 MEXICO PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 157 MEXICO ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 158 MEXICO PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 159 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 160 MEXICO PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 161 MEXICO CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 162 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 163 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 164 MEXICO HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 165 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET : SEGMENTATION

FIGURE 2 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DBMR POSITION GRID

FIGURE 8 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: END USER COVERAGE GRID

FIGURE 10 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASED PREVALENCE OF CHRONIC CARDIAC DISEASES, RISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE SURGERIES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 TO 2029

FIGURE 13 PRODUCT SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 & 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET

FIGURE 15 NORTH AMERICA PREVALENCE AND DISABILITY RATE OF ISCHEMIC HEART DISEASE (IHD) IN 2021

FIGURE 16 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2021

FIGURE 17 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)

FIGURE 18 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 19 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 20 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2021

FIGURE 21 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 22 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 23 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 24 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2021

FIGURE 25 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2022-2029 (USD MILLION)

FIGURE 26 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, CAGR (2022-2029)

FIGURE 27 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 28 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2021

FIGURE 29 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2022-2029 (USD MILLION)

FIGURE 30 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, CAGR (2022-2029)

FIGURE 31 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, LIFELINE CURVE

FIGURE 32 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2021

FIGURE 33 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)

FIGURE 34 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, CAGR (2022-2029)

FIGURE 35 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 36 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2021

FIGURE 37 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 38 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 39 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 41 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 42 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 43 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SNAPSHOT (2021)

FIGURE 45 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021)

FIGURE 46 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 48 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT (2021-2029)

FIGURE 49 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America interventional cardiology and peripheral vascular devices market size will be worth USD 16,651.03 million.
The growth rate of the North America interventional cardiology and peripheral vascular devices market is 7.7%.
Increased prevalence of coronary artery diseases, ischemic heart disease and vascular disease, the surge in awareness about the timely treatment and use of the devices are the growth drivers of the North America interventional cardiology and peripheral vascular devices market.
Product, type, procedure, indication, age group, end user, and distribution channel are the factors on which the North America interventional cardiology and peripheral vascular devices market research is based.
Major companies in the North America interventional cardiology and peripheral vascular devices market are Medtronic, BD., Cordis., Abbott., Boston Scientific Corporation, Cook, Cardiovascular Systems, Inc., AngioDynamics., Edwards Lifesciences Corporation., Biosensors International Group, Ltd., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co.,Ltd and Koninklijke Philips N.V.